Skip to main content
SpringerLink
Log in

Infections in the Immunocompromised Host

  • Chapter
Management of Antimicrobials in Infectious Diseases

Part of the book series: Infectious Disease ((ID))

Abstract

A variety of medical conditions and other factors can cause defects in the humoral and cell-mediated immune defense mechanisms. Individuals with cancer, neutropenic patients, and recipients of solid organ or bone marrow transplants are at high risk for infection, including infection with resistant organisms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Morrison VA. The infectious complications of chronic lymphocytic leukemia Semin Oncol 1998; 25: 98–106.

    CAS  Google Scholar 

  2. Chapel HM, Bunch C. Mechanisms of infection in chronic lymphocytic leukemia. Semin Hematol 1987; 24: 291–296.

    PubMed  CAS  Google Scholar 

  3. Morrison VA, Hibbs JR, Janoff ED. Systemic and mucosal immunoglobulin levels and risk of infection in patients with chronic lymphocytic leukemia and multiple myeloma. Blood 1996; 88:S240a.

    Google Scholar 

  4. Twomey JT. Infections complicating multiple myeloma and chronic lymphocytic leukemia. Arch Intern Med 1973; 132: 562–565.

    Article  PubMed  CAS  Google Scholar 

  5. Byrd JC, Hargis JB, Kester KE, et al. Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis. Am J Hematol 1995; 49: 135–142.

    Article  PubMed  CAS  Google Scholar 

  6. Anaissie E, Kontoyiannis DP, Kantarjian H, et al. Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone. Ann Intern Med 1992; 117: 466–469.

    Article  PubMed  CAS  Google Scholar 

  7. Morrison VA, Rai KR, Peterson B, et al. The impact of therapy with chlorambucil (C), fludarabine (F), or chlorambucil + fludarabine (F+C) on infections in patients with chronic lymphocytic leukemia (CLL): an inner-group study (CALGB 9011). Blood 1998; 92 (Suppl 1):490a (Abstr).

    Google Scholar 

  8. Pomeroy C, Oken MM, Rydell RE, et al. Infection in myelodysplastic syndromes. Am J Med 1991; 90: 338–344.

    PubMed  CAS  Google Scholar 

  9. Oken MM, Pomeroy C, Weisdorf D, et al. Prophylactic antibiotics for the prevention of early infection in multiple myeloma. Am J Med 1996; 100: 624–628.

    Article  PubMed  CAS  Google Scholar 

  10. Antman KS, Griffin JD, Elias A, et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 1988; 319: 593–598.

    Article  PubMed  CAS  Google Scholar 

  11. ASCO Ad Hoc Colony-Stimulating Factor Guideline Expert Panel. American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 1994; 12: 2471–2508.

    Google Scholar 

  12. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. N Engl J Med 1988; 319: 902–907.

    Article  Google Scholar 

  13. Weeks JC, Tierney MR, Weinstein MC. Cost effectiveness of prophylactic intravenous immune globulin in chronic lymophocytic leukemia. N Engl J Med 1991; 325: 81–86.

    Article  PubMed  CAS  Google Scholar 

  14. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323–1332.

    Article  PubMed  CAS  Google Scholar 

  15. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274–1277.

    Article  PubMed  CAS  Google Scholar 

  16. Working Committee, Infectious Diseases Society of America: Hughes WT, Armstrong D, Bodney GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381–396.

    Article  Google Scholar 

  17. Hughes WT, Armstrong D, Bodey GP, et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997; 25: 551–573.

    Article  PubMed  CAS  Google Scholar 

  18. Freifeld A, Marchigiani D, Walsh T, et al. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999; 341: 305–311.

    Article  PubMed  CAS  Google Scholar 

  19. Kern WV, Cometta A, De Bock R, et al. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999; 341: 312–318.

    Article  PubMed  CAS  Google Scholar 

  20. Finberg RW, Talcott JA. Fever and neutropenia-how to use a new treatment strategy. N Engl J Med 1999; 341: 362–363.

    Article  PubMed  CAS  Google Scholar 

  21. Pater R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997; 10: 86–124.

    Google Scholar 

  22. Sia IG, Paya CV. Infectious complications following renal transplantation. Surg Clin North Am 1998; 78: 95–112.

    Article  PubMed  CAS  Google Scholar 

  23. Tsai MK, Lee PH, Hu RH, et al. Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression. Transplant Proc 1998; 30: 3125–3126.

    Article  PubMed  CAS  Google Scholar 

  24. Singh N. Infectious diseases in the liver transplant recipient. Semin Gastrointest Dis 1998; 9: 136–146.

    PubMed  CAS  Google Scholar 

  25. Thaler SJ, Rubin RH. Opportunistic infections in the cardiac transplant patient. Curr Opin Cardiol 1996; 11: 191–203.

    Article  PubMed  CAS  Google Scholar 

  26. Takai K, Tollemar J, Wilczek HE, et al. Urinary tract infections following renal transplantation. Clin Transplant 1998; 12: 19–23, 27.

    Google Scholar 

  27. Singh N, Gayowski T, Wagener MM, et al. Bloodstream infections in liver transplant recipients receiving tacrolimus. Clin Transplant 1997; 11: 275–281.

    PubMed  CAS  Google Scholar 

  28. Singh N, Gayowski T, Wagener MM, et al. Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of microbial etiologies. Transplantation 1996; 61: 396–401.

    Article  PubMed  CAS  Google Scholar 

  29. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27: 1266–1277.

    Article  PubMed  CAS  Google Scholar 

  30. Cisneros JM, Munoz P, Torre-Cisneros J, et al. Pneumonia after heart transplantation: a multiinstitutional study. Spanish Transplantation Infection Study Group. Clin Infect Dis 1998; 27: 324–331.

    Article  PubMed  CAS  Google Scholar 

  31. Chow JW, Yu VL. Legionella: a major opportunistic pathogen in transplant recipients. Semin Respir Infect 1998; 13: 132–139.

    PubMed  CAS  Google Scholar 

  32. Saukkonen K, Garland R, Koziel H. Aerosolized pentamidine as alternative primary prophylaxis against Pneumocystis carinii pneumonia in adult hepatic and renal transplant recipients. Chest 1996; 109: 1250–1255.

    Article  PubMed  CAS  Google Scholar 

  33. Turgeon N, Fishman JA, Tolkoff-Rubin NE, et al. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte globulin therapy. Transplantation 1998; 66: 1780–1786.

    Article  PubMed  CAS  Google Scholar 

  34. Chaparro C, Kesten S. Infections in lung transplant recipients. Clin Chest Med 1997; 18: 339–351.

    Article  PubMed  CAS  Google Scholar 

  35. Dominguez EA, Davis JC, Langnas AN, et al. An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients. Liver Transplant Surg 1997; 3: 586–90.

    Article  CAS  Google Scholar 

  36. Pirsch JD, Maki DG. Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Ann Intern Med 1986; 104: 619–631.

    Article  PubMed  CAS  Google Scholar 

  37. Small TN, Papadopuolos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999; 93: 467–480.

    PubMed  CAS  Google Scholar 

  38. Nemunaitis J, Buckner CD, Dorsey KS, et al. Retrospective analysis of infectious disease in patients who received recombinant human granulocyte-macrophage colony-stimulating factor versus patients not receiving a cytokine who underwent autologous bone marrow transplantation for treatment of lymphoid cancer. Am J Clin Oncol 1998; 21: 341–346.

    Article  PubMed  CAS  Google Scholar 

  39. Meyers JD. Infection in recipients of bone marrow transplants. In: Remington JS, Swartz MN (eds) Current Clinical Topics in Infectious Diseases. New York: McGraw-Hill, 1985, pp. 262–292.

    Google Scholar 

  40. Sparrelid E, Hagglund H, Remberger M, et al. Bacteremia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant 1998; 22: 795–800.

    Article  PubMed  CAS  Google Scholar 

  41. Verfaillie C, Weisdorf D, Haake R, et al. Candida infections in bone marrow transplant recipients. Bone Marrow Transplant 1991; 48: 177–184.

    Google Scholar 

  42. Mossad SB, Longworth DL, Goormastic M, et al. Early infectious complications in autologous bone marrow transplantation; a review of 219 patients. Bone Marrow Transplant 1996; 18: 265–271.

    PubMed  CAS  Google Scholar 

  43. Morrison VA, Haake RF, Weisdorf DJ. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine 1993; 72: 78–89.

    Article  PubMed  CAS  Google Scholar 

  44. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood 1997; 90: 999–1008.

    PubMed  CAS  Google Scholar 

  45. Wald A, Leisenring W, van Burik JA, et al. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459–1466.

    Google Scholar 

  46. Roy V, Ochs L, Weisdorf D. Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis. Leuk Lymphoma 1997; 26: 1–15.

    Article  PubMed  CAS  Google Scholar 

  47. Romano V, Castagnola E, Dallorso S, et al. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 23: 271–275.

    Article  PubMed  CAS  Google Scholar 

  48. Elishoov H, Or R, Strauss N, et al. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine 1998; 77: 83–101.

    Article  PubMed  CAS  Google Scholar 

  49. Serody JS, Shea TC. Prevention of infections in bone marrow transplant recipients. Infect Dis Clin North Am 1997; 11: 459–477.

    Article  PubMed  CAS  Google Scholar 

  50. Arns da Cunha C, Weisdorf D, Sho XO, et al. Early Gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis. Bone Marrow Transplant 1998; 21: 173–180.

    Google Scholar 

  51. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1991; 326: 845–851.

    Article  Google Scholar 

  52. Rousey SR, Sussler S, Gottlieb M, et al. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. Am J Med 1991; 91: 484–492.

    Article  PubMed  CAS  Google Scholar 

  53. Perfect JR, Klotman ME, Gilbert CC, et al. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J Infect Dis 1992; 165: 891–897.

    Article  PubMed  CAS  Google Scholar 

  54. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995; 86: 3598–3603.

    PubMed  CAS  Google Scholar 

  55. Goodrich JM, Bowden RA, Fisher L, et al. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991; 325: 1601–1607.

    Article  PubMed  CAS  Google Scholar 

  56. Winston DJ, Ho WG, Bartoni K, et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients: results of a placebo-controlled, double-blind trial. Ann Intern Med 1993; 118: 179–184.

    Article  PubMed  CAS  Google Scholar 

  57. Stocchi R, Ward KN, Fanin R, et al. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplatation. Haematologica 1999; 84: 71–79.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Vicki A. Morrison
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical University of South Carolina, Charleston, SC, USA

    Arch G. Mainous III PhD

  2. College of Medicine, University of Kentucky, Lexington, KY, USA

    Claire Pomeroy MD

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Morrison, V.A. (2001). Infections in the Immunocompromised Host. In: Mainous, A.G., Pomeroy, C. (eds) Management of Antimicrobials in Infectious Diseases. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-036-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-036-0_18

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5708-8

  • Online ISBN: 978-1-59259-036-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation